Craig Hendrix, MD, on PrEP Medications to Watch Out For
In this podcast, Craig W. Hendrix, MD, discusses pre-exposure prophylaxis (PrEP) medications that are being reviewed by the US Food and Drug Administration, as well as those in clinical trials—a topic he also spoke about at IDWeek 2019.
- Hendrix CW. Prevention strategies on the horizon. Talk presented at: IDWeek 2019; October 2-6, 2019; Washington, DC. https://www.eventscribe.com/uploads/eventScribe/PDFs/2019/6886/891801.pdf.
Craig W. Hendrix, MD, is the Wellcome Professor and director of the Division of Clinical Pharmacology at Johns Hopkins University School of Medicine in Baltimore, Maryland. He is also a professor of medicine in the department of Pharmacology and Molecular Sciences in the Division of Infectious Diseases at the Bloomberg School of Public Health at Johns Hopkins.